Packaging Size | 28 Tablets |
Strength | 400 mg |
Composition | Sofosbuvir |
Treatment | Hepatitis C Infection |
Prescription/Non prescription | Prescription |
Form | Tablet |
Brand | Sofovir |
Manufacturer | Hetero |
Therapeutic Uses | HEPATITIS C LIVER INFECTION |
Packaging Type | Bottles |
Country of Origin | Made in India |
Packaging Size | 28 Tablets |
Composition | Velpatasvir 100 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Packaging Type | Bottles |
Brand | Velakast |
Shelf life | 2 Years |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Velakast is manufactured under license from Gilead Sciences Ireland UC. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor. The tablets include the following inactive ingredients: copovidone, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose. The tablets are film-coated with a coating material containing the following inactive ingredients: Titanium Dioxide IP and Brilliant Blue FCF, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.
Effect of the drug:
Thanks to the powerful composition of the drug, Velakast is widely used to fight the hepatitis C virus of genotypes 1-6. The drug may be given as a monotherapy or for combined treatment with or without cirrhosis. The high effectiveness of the drug against all genotypes of HCV is due to the presence in its composition:
Sofosbuvir:
The IUPAC name for sofosbuvir is (S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran- 2yl)methoxy (phenoxy)phosphorylamino)propanoate. It has a molecular formula of C22H29FN3 O9 P and a molecular weight of 529.45. Sofosbuvir is a white to off-white crystalline solid with a solubility of at least 2 mg/mL across the pH range of 2–7.7 at 37°C and is slightly soluble in water.
Velpatasvir:
The IUPAC name for velpatasvir is Methyl {(1R)-2-[(2S,4S)-2-(5-{2[(2S,5S)-1-{(2S)-2-[(methoxycarbonyl) amino]-3-methylbutanoyl}-5-methylpyrrolidin-2-yl]1,11-dihydro[2]benzopyrano[4′,3′:6,7]naphtho[1,2-d]imidazol-9- yl}-1H-imidazol-2-yl)-4(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl}carbamate. It has a molecular formula of C49H54 N8 O8 and a molecular weight of 883.0. Velpatasvir is practically insoluble (less than 0.1 mg/mL) above pH 5, slightly soluble (3.6 mg/mL) at pH 2, and soluble (greater than 36 mg/mL) at pH 1.2.
Mechanism of Action:
Velakast is a fixed-dose combination of sofosbuvir and velpatasvir which are direct-acting antiviral agents against the hepatitis C virus Sofosbuvir is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. In a biochemical assay, GS-461203 inhibited the polymerase activity of the recombinant NS5B from HCV genotype 1b, 2a, 3a and 4a with an IC50 value ranging from 0.36 to 3.3 micromolar. GS-461203 is neither an inhibitor of human DNA and RNA polymerases nor an inhibitor of mitochondrial RNA polymerase. Velpatasvir is an inhibitor of the HCV NS5A protein, which is required for viral replication. Resistance selection in cell culture and cross-resistance studies indicates velpatasvir targets NS5A as its mode of action.
Composition | Daclatasvir 60 mg |
Treatment | Hepatitis C |
Form | Tablet |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Shelf life | 2 Years |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Brand | Dacikast |
Daclatasvir 60mg is an inhibitor of nonstructural protein 5A (NS5A), a multifunctional protein that is an essential component of the HCV replication complex. Daclatasvir inhibits both viral RNA replication and virion assembly.
Pharmacokinetics
The pharmacokinetic properties of Dasikast (Daclatasvir) were evaluated in healthy adult subjects and in patients with chronic HCV. Following multiple oral doses of Daclatasvir 60 mg once daily in combination with peg interferon alfa and ribavirin in treatment naive patients with genotype 1 chronic HCV, the geometric mean (CV%) Daclatasvir Cmax was 1534 (58) ng/ml, AUC0-24h was 14122 (70) ng*h/ml, and Cmin was 232 (83) ng/ml.
Indications & Usage
Dacikast is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.
Dosage & Administration:
Treatment with Dacikast should be initiated and monitored by a physician experienced in the management of chronic hepatitis C. The recommended dose of Dacikast is 60 mg once daily, to be taken orally with or without meals. Dacikast must be administered in combination with other medicinal products. The Package Inserts of the other medicinal products in the regimen should also be consulted before initiation of therapy with Dacikast.
Contraindications:
Hypersensitivity to the active substance or to any of the Excipients Co-administration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phonation, carbamazepine, oxcarbazepine, phenobarbital, rifampicin, rifabutin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).
Overdosage
There is limited experience of accidental overdose of Daclatasvir in clinical trials. In phase 1 clinical trials, healthy subjects who received up to 100 mg once daily for up to 14 days or single doses up to 200 mg had no unexpected adverse reactions. There is no known antidote for overdose of Daclatasvir. Treatment of overdose with Daclatasvir should consist of general supportive measures, including monitoring of vital signs, and observation of the patient’s clinical status. Because Daclatasvir is highly protein bound (99%) and has a molecular weight >500, dialysis is unlikely to significantly reduce plasma concentrations of Daclatasvir.
Store below 25°C.
Packaging Size | 28 tabs |
Strength | 400mg |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 tablets |
Product Type | Finish Product |
Brand | Mylan |
Manufacturer | Mylan |
MOQ 28 Tab
Strength | 60MG |
Composition | DACLATASVIR 60MG |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Packaging Type | Bottle |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Usage | Hospital, Clinical |
Brand | NATDAC |
Manufacturer | NATCO |
Shelf life | MORE THAN 2 YEARS |
Therapeutic Uses | HEPATITIS C LIVER INFECTION |
Country of Origin | Made in India |
Medicine Type | Allopathic |
Packaging Size | 28 tablets |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative NATDAC Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Other Details: 28 Tablets.
Packaging Size | 28 tabs |
Strength | 60MG |
Composition | DACLATASVIR 60MG |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Packaging Type | 28 tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Brand | Mylan |
Manufacturer | Mylan |
Other Details: 28 Tablets.
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg & Daclatasvir 60 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Hepcinat Plus |
Manufacturer | Natco |
Shelf life | 2 Years |
Packaging Type | Bottles |
Hepcinat Plus tablet is an antiviral medication. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks.
Packaging Size | 28 Tablets |
Strength | 400mg & 60mg |
Composition | Sofosbuvir400mg + Daclatasvir 60mg |
Treatment | Hepatitis C Infection |
Prescription/Non prescription | Prescription |
Form | Tablet |
Brand | Sofokast Plus |
Manufacturer | Natco Pharma Ltd. |
Shelf life | 2 YEARS |
Packaging Type | Bottles |
Country of Origin | Made in India |
Sofokast plus tablets, which contain 400 mg Sofosbuvir is a nucleotide polymerase inhibitor, and includes antiviral drugs direct action. sofosbuvir is exposed to have a high barrier to growth resistance and inhibits the Cb NS5B Hep protein. Thus, Sofosbuvir interferes with the enzyme RNA polymerase by a cell worker who can perform the reproduction process. Consequently, Sofosbuvir stops hepatitis C virus replication and reduces the amount of Hep C virus in the liver. Sofosbuvir also acts to reduce liver damage and improve liver function.
Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.
Packaging Size | 28 Tablets |
Composition | Daclatasvir 60 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | DaciHep |
Manufacturer | Zydus Heptiza |
Shelf life | 2 Years |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Sofokast |
Manufacturer | Natco |
Shelf life | 2 Years |
Packaging Type | Box |
Sofokast is manufactured under license from Gilead Sciences Ireland UC.
Indications for use of the drug:
The drug Sofosbuvir 400 mg is prescribed for patients with hepatitis C when the disease has passed into a chronic form. A combined approach is used for the effectiveness of treatment. It is possible to use medicament in cases when the patient has HIV in addition to hepatitis.
Contraindications to taking the drug “Sofosbuvir”:
The drug is not used for hypersensitivity to substances that are present in its composition. Despite the fact that the drug does not affect fertility, it is rarely prescribed to women in their reproductive years. The use of the drug during pregnancy and breastfeeding is not recommended, as it can be harmful to the child. When pregnancy occurs, the combination of Sofosbuvir with such drugs as Interferon alfa and Ribavirin may have a negative effect on its course. For this reason, during the period of treatment, the child’s bearing is undesirable. The experiments, during which the drug “buy sofosbuvir online” was tested in animals, showed that this drug has a slightly negative impact on the offspring. Before you start taking it, you should carefully study the instructions for the drug and consult with a specialist.
Side Effect:
Packaging Size | 28 Tablets |
Strength | 400mg |
Composition | Sofosbuvir400mg |
Treatment | Hepatitis C Infection |
Prescription/Non prescription | Prescription |
Form | Tablet |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Manufacturer | Glenmark Pharmaceuticals |
Shelf life | MORE THAN 2 YEARS |
Composition | Ledipasvir 90 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Ledikast |
Shelf life | 2 Years |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Manufacturer | Natco |
Ledikast is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase.
The tablet includes the following inactive ingredients: Colloidal silicon dioxide, copovidone, croscarmellose sodium, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.
The tablet is film-coated with a coating material containing the following inactive ingredients: Yellow Oxide of Iron, polyethylene glycol, polyvinyl alcohol, talc, FD&C Blue #2 and titanium dioxide IP.
Based on drug interaction studies conducted with individual drugs Ledipasvir or Sofosbuvir or combination of Ledipasvir + Sofosbuvir, no clinically significant drug interactions have either been observed or are expected when Ledipasvir + Sofosbuvir is used with the following drugs individually: abacavir, atazanavir/ritonavir, cyclosporine, darunavir/ ritonavir, efavirenz, emtricitabine, lamivudine, , oral contraceptives, pravastatin, raltegravir, rilpivirine, tacrolimus, tenofovir disoproxil fumarate, or verapamil.
Ledikast is manufactured under license from Gilead Sciences Ireland UC.
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg & Ledipasvir 90 mg |
Treatment | Hepatitis C |
Form | Tablet |
Packaging Type | Bottle |
Brand | Hepcinat-LP |
Manufacturer | Natco |
We are offering Hepcinat-LP Ledipasvir & Sofosbuvir Tablets to our clients.
Note:
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg & Velpatasvir 100 mg |
Treatment | Chronic Hepatitis C |
Form | Tablet |
Product Type | Bottle |
Brand | Resof Total |
Manufacturer | Dr. Reddy's |
Packaging Type | Bottles |
Resof Total medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Common Side Effects:
Headache, tired feeling, nausea, diarrhea; or sleep problems (insomnia).
Call your doctor at once if you have slow heartbeats; weak or shallow breathing; or low red blood cells-pale skin, weakness, rapid heart rate, trouble concentrating.
If you also take amiodarone:
Seek medical help right away if you feel weak, tired, or light-headed, or if you have chest pain, shortness of breath, confusion, or memory problems.
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg, Velpatasvir 100 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Velpanat |
Manufacturer | Natco |
Shelf life | 2 Years |
Packaging Type | Bottles |
Velpanat (Sofosbuvir 400 mg + Velpatasvir 100 mg) is a combinational anti-Hepatitis C drug used in patients with genotype 1 to 6. The combined inhibitory action of Sofosbuvir 400 mg and Velpatasvir 100 mg, allows 93-99% of overall response rate against HCV cells.
The tablet is taken orally once daily with or without food. In situations where the patients are at higher risk of liver disease, ribavirin is also added for a constant response.
Velpanat (Sofosbuvir + Velpatasvir) has one of the highest sustained viral response (SVR) amongst combined anti-HCV agents. However, the SVR differs based on the type of liver disease associated with HCV.
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg & Velpatasvir 100 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Velasof |
Manufacturer | Hetero |
Packaging Type | Bottles |
Velpatasvir Sofosbuvir (Velasof) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Indication:
Velasof (Sofosbuvir 400 mg velpatasvir 100 mg) is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.
The combination of sofosbuvir and velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
Brand Name | Ribasure |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Packaging Size | 28 Tablets |
Packaging Type | Bottle |
Composition | Ribavirin USP 200 mg |
Form | Capsules |
Treatment | Hepatitis C |
Ribavirin (Ribasure) is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which Ribasure in combination with other medicinal products exerts its effects against HCV is unknown.
Pharmacodynamics:
The antiviral activity of Ribavirin in the HCV-replicon is not well understood and has not been defined because of the cellular toxicity of Ribavirin.
Resistance HCV genotypes show wide variability in their response to pegylated recombinant human interferon/ribavirin therapy. Genetic changes associated with the variable response have not been identified.
Cross-resistance:
There is no reported cross-resistance between pegylated/non-pegylated interferons and Ribavirin.
Pharmacokinetics:
Ribavirin is absorbed rapidly following oral administration of a single dose (mean Tmax= 1.5 hours), followed by rapid distribution and prolonged elimination phases (single dose half-lives of absorption, distribution and elimination are 0.05, 3.73 and 79 hours, respectively). Absorption is extensive with approximately 10 % of a radiolabelled dose excreted in the faeces. However, absolute bioavailability is approximately 45 %-65 %, which appears to be due to first pass metabolism.
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Brand | Viroclear |
Manufacturer | Abbott |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Resof |
Manufacturer | Dr. Reddy's |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Cimivir |
Manufacturer | Biocon |
Packaging Type | Bottles |
Packaging Size | 28 Tablets |
Packaging Type | Bottle |
Composition | Daclatasvir 60 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Hepcfix |
Manufacturer | Dr. Reddy's |
Minimum Order Quantity | 28 Bottle |
Packaging Size | 28 Tablets |
Composition | Daclatasvir 60 mg |
Treatment | Hepatitis C |
Form | Tablet |
Packaging Type | Bottle |
Brand | Daclacure |
Manufacturer | Emcure |
We are offering Daclacure Daclatasvir Dihydrochloride Tablets to our clients.
Minimum Order Quantity | 3 Bottle |
Packaging Size | 28 Tablets |
Composition | Ledipasvir 90 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | Virpas |
Manufacturer | Strides |
Shelf life | 2 Years |
Packaging Type | Bottles |
We are offering Virpas Ledipasvir & Sofosbuvir Tablets to our clients.
Packaging Size | 28 tabs |
Strength | 400/100 mg |
Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Mylan |
Manufacturer | Mylan |
Form | Tablet |
Strength/Dose (in mg or ml) | Velpatasvir 100mg and Sofosbuvir 400 mg |
Pack Size | 28 Tab |
Product Type | Finish Product |
MyHep All medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover
MEDICINE USES :MyLan Pharmaceutical Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
SOFOSBUVIR VELPATASVIR COMMON SIDE EFFECTS :Common MyHep All side effects may include:
Packaging Size | 28 Tab |
Strength | 60 mg |
Composition | Daclatasvir |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Cipla |
Manufacturer | Hetero |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if daclatasvir prevents the spread of hepatitis C to other people.
How should this medicine be used?Daclatasvir comes as a tablet to take by mouth. It is usually taken with or without food once a day. Daclatasvir must be taken in combination with sofosbuvir, usually for 12 weeks. Take daclatasvir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take daclatasvir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Continue to take daclatasvir even if you feel well. Do not stop taking daclatasvir or sofosbuvir without talking to your doctor.
Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.
Other uses for this medicineThis medication may be prescribed for other uses; ask your doctor or pharmacist for more information
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Form | Tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Dose | 200 mg |
EMVARIN MEDICINE
Emvarin medicine contains Ribavirin 200 mg in it. It comes in the form of capsules.Emvarin medicine is manufactured by Emcure.
Product Details:
A. Name of Medicine: EmvarinB. Chemical Used: Ribavirin Capsules USP 200 mgC. Available as: CapsulesD. Strength: 200 MgE. Packing: 28 capsulesF. Manufacturing Company: EmcureWe are suppliers/exporters of Emvarin capsules from Delhi,India. Emvarin medicine is available at discount.
Attention: The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking,check with your doctor, nurse or pharmacist.Emvarin is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Packaging Size | 28 Tablets |
Brand | Hepcvir L |
Composition | Ledipasvir 90 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Packaging Type | Bottle |
Manufacturer | Cipla Ltd |
Hepcvir L is a combination of two hepatitis C virus (HCV) antiviral drugs in a single form. Each single tablet contains ledipasvir and sofosbuvir.
Uses:
Common Side Effects:
Packaging Size | 28 Tablets |
Composition | Ledipasvir 90 mg & Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Form | Tablet |
Brand | MyHep LVIR |
Manufacturer | Mylan |
Packaging Type | Bottles |
Prescription/Non prescription | Prescription |
Form | Tablet |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Packaging Type | 15 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 400 mg |
Usage | Clinical |
Other Details: 15 Tablets.